Melanotan-2 (MT-2) (10mg)

Research Overview

A cyclic heptapeptide and non-selective melanocortin receptor agonist. Melanotan II activates MC1R (melanogenesis), MC3R, MC4R (sexual function/appetite), and MC5R, giving it a broad biological profile. It was the parent compound from which PT-141 was derived.

Origin: Developed at University of Arizona as a melanocortin agonist

Mechanism of Action

• MC1R agonism (melanin production)

• MC4R agonism (sexual function, appetite)

• MC3R agonism

• Broad melanocortin receptor activation

• UV-independent melanogenesis

Primary Research Areas

• Melanogenesis

• UV-independent tanning research

• Sexual function

• Appetite regulation

Key Published Findings

• Stimulated melanin production and UV-independent skin darkening in human subjects

• Parent compound for PT-141; demonstrated sexual function effects via MC4R

• Broad melanocortin activation profile limits clinical selectivity

Research Protocol

Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.

Storage

-20°C lyophilized

Important Notice

Melanotan-2 (MT-2) (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.